Anti-Cancer Agents in Medicinal Chemistry
Title:Editorial (Thematic Issue: Antitarget Therapies: New Frontiers in the Treatment of Cancer)
Volume: 16 Issue: 1
Author(s): Claudio Festuccia, Alessio Lodola and Giovanni Luca Gravina
Affiliation:
Export Options
About this article
Cite this article as:
Festuccia Claudio, Lodola Alessio and Gravina Luca Giovanni, Editorial (Thematic Issue: Antitarget Therapies: New Frontiers in the Treatment of Cancer), Anti-Cancer Agents in Medicinal Chemistry 2016; 16 (1) . https://dx.doi.org/10.2174/1871520615999150907124551
DOI https://dx.doi.org/10.2174/1871520615999150907124551 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1
Current Pharmaceutical Biotechnology NF-κB Inhibitors in Head and Neck Cancer
Letters in Drug Design & Discovery Perspectives on Chemopreventive and Therapeutic Potential of Curcumin Analogs in Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry From Body Art to Anticancer Activities: Perspectives on Medicinal Properties of Henna
Current Drug Targets The Preclinical Bases of the Rational Combination of Paclitaxel and Antiangiogenic Drugs
Clinical Cancer Drugs Drugs Interfering with Apoptosis in Breast Cancer
Current Pharmaceutical Design Antifolate Inhibitors of Thymidylate Synthase as Anticancer Drugs
Mini-Reviews in Medicinal Chemistry The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies
Current Pharmaceutical Design The Multifaceted Activities of Mammalian Defensins
Current Pharmaceutical Design Subject Index to Volume 4
Current Cancer Drug Targets Therapeutic Use of Molecules that Mimic Pathogen Danger Signals
Endocrine, Metabolic & Immune Disorders - Drug Targets Pediatric Cutaneous Graft Versus Host Disease: A Review
Current Pediatric Reviews Bevacizumab in Non Small Cell Lung Cancer: Development, Current Status and Issues
Current Medicinal Chemistry Apoptosis and Apoptosis-Based Therapy in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?
Current Medicinal Chemistry New Molecular Targets in the Treatment of NSCLC
Current Pharmaceutical Design